Behçet's syndrome (BS) is a complex vasculitis, characterised by peculiar histological,
pathogenetic and clinical features. Superficial venous thrombosis (SVT) and deep vein …

Behçet's disease is a systemic vasculitis characterized by attacks of acute inflammation,
which can affect almost every vascularized area of the body. There is a close correlation …

Abstract Purpose of Review To assess current management of Behcet's disease (BD).
Controversies on therapeutic approaches to different manifestations, whether conventional …

Behçet's syndrome (BS) is a multisystemic vasculitis, characterized by different clinical
involvements, including mucocutaneous, ocular, vascular, neurological, and gastrointestinal …

Macular edema (ME) represents the most common cause for visual loss among uveitis
patients. The management of uveitic macular edema (UME) may be challenging, due to its …

To compare the efficacy of adalimumab (ADA) and infliximab (IFX) in patients with non-
infectious intermediate uveitis, posterior uveitis, and panuveitis. Demographic, clinical …

Non-infectious uveitis are intraocular inflammatory conditions caused by dysregulated
activation of the immune response without any detectable infectious agents. The aim of this …

Behçet's syndrome (BS) is a complex disease that shows important heterogeneity in clinical
findings and physiopathology. Its treatment can be problematic as BS manifestations in …

Behçet's disease is a systemic vasculitis that affects multiple organs. The most common
manifestations are oral and genital ulcerations and recurrent uveitis. Uveitis can be an initial …

Objective Since Behçet's syndrome (BS) is the prototype of inflammation‐induced
thrombosis, immunosuppressants are recommended in place of anticoagulants. We …